Haemonetics (NYSE: HAE)
Haemonetics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Haemonetics Company Info
Haemonetics Corp. is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
News & Analysis
Why Haemonetics Stock Dived by 15% Today
The company broadly meets expectations for its Q2 2022 but trims its full-year guidance.
Why Haemonetics Stock Rallied on Friday
One analyst upgrade in particular seemed to bring back the bulls.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.